期刊文献+

miR-21在宫颈鳞癌淋巴结转移患者血清中的表达及其临床意义 被引量:5

Expression of miR-21 in squamous cell carcinoma of cervix with lymph node metastasis and its clinical significance
下载PDF
导出
摘要 目的:探讨miR-21在宫颈鳞癌患者血清中的表达及其与淋巴结转移的相关性。方法:选择2011年1-8月在广西医科大学附属肿瘤医院妇瘤科住院接受治疗的74例患者为研究对象,其中,宫颈鳞癌伴淋巴结转移者23例,宫颈鳞癌不伴淋巴结转移者39例,正常对照组12例,应用茎环实时荧光逆转录聚合酶链反应(real-time RT-PCR)检测血清标本中miR-21表达情况。采用多个独立样本的非参数检验分析,对其中任意两组的比较采用秩和检验分析。结果:3组miR-21表达水平差异有显著性(P<0.05),对3组进行两两比较,宫颈鳞癌伴淋巴结转移组的血清miR-21表达水平较不伴淋巴结转移组及正常对照组升高(P<0.05),差异有统计学意义(P>0.05),宫颈鳞癌不伴淋巴结转移组血清中miR-21表达水平同正常对照组比较,差异无统计学意义(P>0.05)。结论:血清miR-21在宫颈鳞癌淋巴结转移预测方面有一定的临床价值。 Objective To explore the expression of miR-21 in squamous cell carcinoma of cervix and the correlation with lymph node metastasis (LNM). Methods The patients of 74 women were obtained from January 2011 to August 2011 in Guangxi medical university cancer hospital, applied hairpin of real-time RT-PCR to detect the expression level of serum miR-21.23 cases were squamous cell carcinoma of cervix with LNM, 39 cases were squamous cell carcinoma ~f cervix without LNM, 12 cases were normal control. Applied non-parametric test for multiple independent samples, each two group with rank sum test. Results There were statistically significant correlations between the three groups (P 〈 0.05). The serum miR-21 level of cervical cancer cases with LNM was higher than the other two groups. There was no statistical significance between cervical cancer without LNM and normal control group. Conclusion Serum miR-21 may have its clinical value in predicting LNM in cervical cancer.
出处 《实用医学杂志》 CAS 北大核心 2012年第19期3195-3197,共3页 The Journal of Practical Medicine
基金 广西自然科学基金资助项目(编号:2011GXNSFA018184) 广西研究生教育创新计划资助项目(编号:2011105981002M182)
关键词 宫颈肿瘤 MIR-21 淋巴结转移 血清 Uterine cervical neoplasms miR-21 Lymph node metastasis Serum
  • 相关文献

参考文献2

二级参考文献71

  • 1Pillai RS. MicroRNA function: multiple mechanisms for a tiny RNA? RNA 2005; 11:1753-1761.
  • 2Zamore PD, Haley B. Ribo-gnome: the big world of small RNAs. Science 2005; 309:1519-1524.
  • 3Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116:281-297.
  • 4Fitzgerald K. RNAi versus small molecules: different mechanisms and specificities can lead to different outcomes. Curr Opin Drug Discov Dev 2005, 8:557-566.
  • 5Brennecke J, Stark A, Russell R.B, Cohen SM. Principles of microRNA-target recognition. PLoS Biol.2005; 3:e85.
  • 6Croce CM, Calin GA. miRNAs, cancer, and stem cell division. Cell 2005; 122:6-7.
  • 7Chen CZ, Li L, Lodish HF, Bartel DE MicroRNAs modulate hematopoietic lineage differentiation. Science 2004; 303:83- 86.
  • 8Hwang HW, Mendell JT. MicroRNAs in cell proliferation, cell death, and tumorigenesis. Br J Cancer 2006; 94:776-780.
  • 9Hammond SM. MicroRNAs as oncogenes. Curr Opin Genet Dev 2006; 16:4-9.
  • 10Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006; 6:259-269.

共引文献1177

同被引文献68

  • 1冯淑瑜,张彦娜,刘建刚.宫颈癌淋巴结转移的高危因素及预后分析[J].癌症,2005,24(10):1261-1266. 被引量:71
  • 2Guo K, Yang Y, Qiu J, et al. The expression profile ofmicroRNAs in wistar rats with lipopolysaccharide-induced periventricular leukomalacia[J]. J Mol Neurosci, 2013, 51(3): 941-949.
  • 3Srinivasan S, Selvan ST, Archunan G, et al. MicroRNAs -the next generation therapeutic targets in human diseases [J]. Theranostics, 2013,3(12): 930-942.
  • 4Xi Y. MicroRNA: A New Player for Cancer Chemoprevention[J]. J Integr Oncol, 2013, 2(1): 105.
  • 5Zen K, Zhang CY. Circulating microRNAs: a novel class of biomarkers to diagnose and monitor human cancers [J]. Med Res Rev, 2012, 32(2): 326-348.
  • 6Zou J, Li WQ, Li Q, et al. Two functional microRNA-126s repress a novel target gene p21-activated kinase 1 to regulate vascular integrity in zebrafish[J]. Circ Res, 2011,108(2): 201-209.
  • 7Bradl M, Lassmann H. Oligodendrocytes: biology and pathology [J]. Acta Neuropathol, 2010,119(1): 37-53.
  • 8Back SA. Cerebral White and Gray Matter Injury in Newborns: New Insights into Pathophysiology and Management [J]. Clin Perinatol, 2014, 41(1): 1-24.
  • 9Dugas JC, Cuellar TL, Scholze A, et al. Dicer! and miR-219 Are required for normal oligodendrocyte differentiation and myelination[J]. Neuron, 2010, 65(5): 597-611.
  • 10Zhao X, He X, Han X, et al. MicroRNA-mediated control of oligodendrocyte differentiation[J]. Neuron, 2010, 65(5): 612-626.

引证文献5

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部